Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
Ruth Fernandez‐Ruiz, Jacqueline L Paredes, Timothy B. Niewold
Translational research (2020) Vol. 232, pp. 13-36
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 167
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination
Peter Izmirly, Mimi Kim, Marie I. Samanovic, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 284-294
Open Access | Times Cited: 132
A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
Kenneth Kalunian, Richard Furie, Eric F. Morand, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 2, pp. 253-265
Open Access | Times Cited: 94
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 90
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications
Juan Liu, Xiaomin Zhang, Xuetao Cao
Journal of Autoimmunity (2022) Vol. 132, pp. 102856-102856
Closed Access | Times Cited: 45
The Use of COVID-19 Vaccines in Patients with SLE
Wei Tang, Yevgeniya Gartshteyn, Edd Ricker, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 11
Open Access | Times Cited: 41
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 34
Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID‐19 outcomes: Genome‐wide cross trait analysis and bidirectional Mendelian randomization study
Minhao Yao, Xin Huang, Yunshan Guo, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 22
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
Zahra Hamidi, Shaghaiegh Jabraeili-Siahroud, Yalda Taati-Alamdari, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Disparities in Lupus and the Role of Social Determinants of Health: Current State of Knowledge and Directions for Future Research
Joy Buie, Emma McMillan, J.D. Kirby, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 9, pp. 454-464
Open Access | Times Cited: 18
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
(2021)
Open Access | Times Cited: 37
Coronavirus disease 2019 (COVID-19) and autoimmunity
Е. Л. Насонов
Rheumatology Science and Practice (2021) Vol. 59, Iss. 1, pp. 5-30
Open Access | Times Cited: 33
Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
Nuntawan Piyaphanee, Sirirat Charuvanij, Sutheera Thepveera, et al.
Lupus (2024) Vol. 33, Iss. 5, pp. 450-461
Closed Access | Times Cited: 5
Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches
Shudeb Babu Sen Omit, Salma Akhter, Humayan Kabir Rana, et al.
BioMed Research International (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 12
Long-term consequences of COVID-19 on mental health and the impact of a physically active lifestyle: a narrative review
Leonardo Roever, Bruno Raphael Ribeiro Cavalcante, Alex Cleber Improta‐Caria
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico
Lilliana Serrano-Arroyo, Ariana González-Meléndez, Rafael Ríos-Rivera, et al.
Lupus (2025)
Closed Access
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies
Mario Ferraioli, Alessandra Aiello, I. Prevete, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 396-396
Open Access
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study
Arthur Mageau, T. Papo, Stéphane Ruckly, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 4, pp. 569-574
Open Access | Times Cited: 25
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
Ilona Nln, Ruth Fernandez‐Ruiz, Theresa Wampler Muskardin, et al.
Translational research (2022) Vol. 244, pp. 47-55
Open Access | Times Cited: 17
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
Xiaofeng Jiang, Jeffrey A. Sparks, Zachary S. Wallace, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002839-e002839
Open Access | Times Cited: 10
Systemic Lupus Erythematosus and Cytokine Storm
Roberto Caricchio, Stefania Gallucci
Advances in experimental medicine and biology (2024), pp. 355-364
Closed Access | Times Cited: 3
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
Amit Saxena, Allison Guttmann, Mala Masson, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 8, pp. e585-e594
Open Access | Times Cited: 22
The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study
Fawzi Babtain, Abdulaziz Bajafar, Ohoud Nazmi, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 65, pp. 103985-103985
Open Access | Times Cited: 15
A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus
M. S. Rao, Jamal Mikdashi
Open Access Rheumatology Research and Reviews (2023) Vol. Volume 15, pp. 125-137
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top